Last Updated: 01/01/2025

Development of human blood-stage challenge model for vaccine testing

Objectives

Partner Institutions

PATH, United States
University of Oxford, United Kingdom
Walter Reed Army Institute of Research (WRAIR), United States
GlaxoSmithKline (GSK), United Kingdom

Themes

Basic Science
Vaccines

Country / Project Site(s)

United Kingdom
United States

SHARE

Related Resources

PATH Webinar: What’s next with malaria vaccines?
PATH Webinar: What’s next with malaria vaccines?
Report of an expert consultation on the clinical development plan for a multistage malaria vaccine targeting the circumsporozoite (CS) and blood stage (BS) antigens
Report of an expert consultation on the clinical development plan for a multistage malaria vaccine targeting the circumsporozoite (CS) and blood stage (BS) antigens
Towards a vaccine for Plasmodium vivax: Landscaping review (updated poster)
Towards a vaccine for Plasmodium vivax: Landscaping review (updated poster)

Related Projects

Jun 2008 —
May 2014
Development of a P. vivax immunization and sporozoite challenge model for human
Jun 2022 —
Mar 2024
Development of experimental model for surface antigens of human malaria parasite
Dec 2017 —
Apr 2018
Malaria Controlled Human Infection Model – application development
SHARE